Jacobs Levy Equity Management’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
FLAM
PCH
AIM
WA
Jacobs Levy Equity Management's AXGN Position: Q2 2026 in Review
Jacobs Levy Equity Management increased its Axogen (AXGN) stake by 0.46% in Q2 2026, buying an estimated $71.3K and bringing the position to 386,423 shares worth $17.8M. The position accounts for 0.06% of the portfolio, ranked #238.
Jacobs Levy Equity Management first reported a position in AXGN in Q4 2019 and has held it in 25 quarters since. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.
- Jacobs Levy Equity Management held 386,423 shares of Axogen worth $17.8M as of Q2 2026.
- Jacobs Levy Equity Management bought 1,769 Axogen shares in Q2 2026, an estimated $71.3K.
- Axogen made up 0.06% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #238 holding.
- Jacobs Levy Equity Management first reported a position in Axogen in Q4 2019 and has held it in 25 quarters since.
- 254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.